NaniRx Therapeutics' Series A Round

NaniRx Therapeutics raised a round of funding on , .

NaniRx is a drug development company affiliated with Columbia University Medical Center with a primary focus on Precision Immune-Stimulants (PINS) for the treatment of breast cancer and on Precision T…

Articles about NaniRx Therapeutics' Series A Round: